Immupharma (IMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

8.50p
   
  • Change Today:
      0.25p
  • 52 Week High: 17.60
  • 52 Week Low: 1.50
  • Currency: UK Pounds
  • Shares Issued: 502.72m
  • Volume: 1,684,357
  • Market Cap: £42.73m
  • RiskGrade: 328
  • Beta: 0.99

Deal with Barclays    Trade now with Barclays Stockbrokers

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Timothy Paul McCarthy 1,488,462 £126,519
Lisa Baderoon 583,963 £49,637
Tim Franklin 525,000 £44,625

Major Shareholders

Notifier** Holding Value*
Lanstead Capital LP 25,108,044 £2,134,184
Invesco Ltd 17,872,341 £1,519,149
Aviva Investors Global 11,285,180 £959,240
Alora Pharmaceuticals LLC 10,909,091 £927,273
M&G Investments 7,600,000 £646,000
Prudential plc 7,600,000 £646,000
Capital Income Builder 4,870,367 £413,981
Dr R Zimmer 4,551,553 £386,882
Odey Asset Management 3,433,319 £291,832
Rhone Trustees (Switzerland) SA 3,386,000 £287,810
Pictet Overseas Trust Corporation Limited 3,287,500 £279,438

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Immupharma Market Data

Currency UK Pounds
Share Price 8.50p
Change Today 0.25p
% Change 3.03 %
52 Week High 17.60
52 Week Low 1.50
Volume 1,684,357
Shares Issued 502.72m
Market Cap £42.73m
Beta 0.99
RiskGrade 328

Immupharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
29.39% below the market average29.39% below the market average29.39% below the market average29.39% below the market average29.39% below the market average
21.95% above the sector average21.95% above the sector average21.95% above the sector average21.95% above the sector average21.95% above the sector average
Price Trend
67.97% below the market average67.97% below the market average67.97% below the market average67.97% below the market average67.97% below the market average
40.91% below the sector average40.91% below the sector average40.91% below the sector average40.91% below the sector average40.91% below the sector average
Income Not Available
Growth Not Available

Immupharma Dividends

No dividends found

Trades for 20-Feb-2026

Time Volume / Share Price
16:19 189,432 @ 8.33p
16:25 1,463 @ 8.33p
16:24 2,200 @ 8.02p
16:22 10,670 @ 8.33p
16:18 37 @ 8.02p

Immupharma Key Personnel

CEO Timothy Paul McCarthy

Top of Page